Chikungunya Outbreak in Mayotte: 100 New Cases Reported

Mayotte, a French overseas department in the Indian Ocean, is experiencing a significant resurgence of chikungunya virus transmission, with health authorities reporting over a hundred latest cases in recent weeks. This uptick follows a broader regional trend affecting nearby La Réunion, where tens of thousands of cases have been recorded since mid-2024. The current situation in Mayotte marks a notable escalation after years of minimal local transmission, raising concerns among public health officials about the potential for sustained community spread.

The chikungunya virus, primarily transmitted through the bite of infected Aedes mosquitoes, causes symptoms including sudden fever, severe joint pain, muscle aches, headache, and rash. While most individuals recover within a week, some experience debilitating joint pain that can persist for months or even years. Vulnerable populations such as newborns, older adults, and those with underlying health conditions face a higher risk of severe outcomes. There is no specific antiviral treatment; care focuses on symptom relief through hydration, rest, and analgesics.

According to verified data from the World Health Organization (WHO), widespread transmission of chikungunya has been documented in La Réunion since August 2024, with over 47,500 confirmed cases and twelve associated deaths reported as of May 4, 2025. In Mayotte, the first locally transmitted cases since the 2005–2006 outbreak were detected in late 2024, signaling a return of the virus after nearly two decades of absence. By mid-May 2025, Mayotte had recorded 205 chikungunya cases, reflecting a steady increase in local transmission.

The U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 2 travel health notice for Mayotte, advising travelers to practice enhanced precautions due to the ongoing outbreak. The notice emphasizes that mosquitoes spread the virus and recommends preventive measures such as using EPA-registered insect repellent, wearing long-sleeved clothing, and staying in accommodations with air conditioning or window screens. Vaccination is recommended for travelers visiting outbreak areas, though it should be deferred until after pregnancy due to risks of mother-to-child transmission around the time of delivery.

Public health responses in both La Réunion and Mayotte have included enhanced surveillance, vector control initiatives such as larviciding and fumigation, and community awareness campaigns. In La Réunion, health authorities reported a more than 100-fold increase in weekly case counts between late 2024 and March 2025, peaking at 4,000 cases during epidemiological week 11. Hospitalizations have occurred, with 340 recorded from January to May 2025; nearly half of hospitalized patients were over 65 years old, and about a quarter were infants under six months.

Although most chikungunya infections are not fatal, the disease can impose a significant burden on healthcare systems and disrupt daily life due to prolonged arthritic symptoms. Long-term complications, while uncommon, may include persistent joint inflammation resembling rheumatoid arthritis, particularly in older individuals. Researchers continue to study the virus’s pathogenesis and potential long-term effects, but no licensed vaccine is currently available for general public apply outside of specific travel or outbreak-response contexts.

For residents and visitors in Mayotte, staying informed through official channels is critical. The Agence régionale de santé (ARS) of Mayotte and La Réunion regularly updates case numbers and prevention guidance. Travelers should consult the CDC’s Travelers’ Health page or the WHO’s Disease Outbreak News for the latest advisories before planning trips to the Indian Ocean region.

As of the most recent verified reports, health officials continue to monitor the situation closely, with vector control efforts intensified in high-transmission zones. There is no indication of an imminent nationwide vaccination campaign, but targeted outreach remains a priority in vulnerable communities. The next official update on case numbers and public health measures is expected from regional health agencies in the coming weeks, based on routine surveillance reporting cycles.

Stay informed about global health developments by following trusted sources such as the World Health Organization and the Centers for Disease Control, and Prevention. Share this article to help others stay aware of emerging health risks in tropical regions.